Position in IMVT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$66,888,080
-$21,664,433 QoQ
Shares Held
1,736,000
-51.3% QoQ
Ownership
0.840%
of shares outstanding
% of Portfolio
1.86%
of 13F equity value
Holder Rank
#20
of 224 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IMVT Over Time
Shares Held
Position Value (USD)
Derivatives in IMVT
reported options exposure · as of Jun 30, 2026CallValue
$46,236,000
CallShares
1,200,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026ARMISTICE CAPITAL, LLC holds $1,506,954,940 across 50 Biotechnology names. IMVT ranks #8 (4.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
288,000 | $154,641,600 | |
| 2 | CYTK |
Cytokinetics Inc
|
1,201,342 | $102,342,324 | |
| 3 | INCY |
Incyte Corp
|
900,005 | $102,024,566 | |
| 4 | TVTX |
Travere Therapeutics, Inc.
|
1,572,539 | $89,335,940 | |
| 5 | AGIO |
Agios Pharmaceuticals, Inc.
|
2,400,000 | $89,064,000 | |
| 6 | PTCT |
Ptc Therapeutics, Inc.
|
1,071,395 | $87,393,690 | |
| 7 | DYN |
Dyne Therapeutics, Inc.
|
3,087,226 | $68,567,289 | |
| 8 | IMVT |
Immunovant, Inc.
This page
|
1,736,000 | $66,888,080 |
All Filings in IMVT
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $66,888,080 | 1,736,000 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $46,236,000 | 1,200,000 | Call | Sole | 2026-08-14 | |
| 2026-03-31 | $47,196,000 | 1,900,000 | Call | Sole | 2026-05-15 | |
| 2026-03-31 | $88,552,513 | 3,564,916 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $19,065,000 | 750,000 | Call | Sole | 2026-02-17 | |
| 2025-12-31 | $146,092,680 | 5,747,155 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $94,076,320 | 5,836,000 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $83,200,000 | 5,200,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $76,905,000 | 4,500,000 | Shares | Sole | 2025-05-15 | |
| 2025-03-31 | $15,381,000 | 900,000 | Call | Sole | 2025-05-15 | |
| 2024-12-31 | $33,439,500 | 1,350,000 | Call | Sole | 2025-02-14 | |
| 2024-12-31 | $95,874,415 | 3,870,586 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $101,153,480 | 3,548,000 | Shares | Sole | 2024-11-14 | |
| 2024-09-30 | $16,535,800 | 580,000 | Call | Sole | 2024-11-14 | |
| 2024-06-30 | $89,678,397 | 3,396,909 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $69,918,840 | 2,164,000 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $60,498,680 | 1,436,000 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $39,767,318 | 1,035,877 | Shares | Sole | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||